South Africa has secured over $29 million from the Global Fund to purchase lenacapavir, a biannual anti-HIV injection, which research indicates could significantly contribute to ending AIDS in the country, according to health department spokesperson Foster Mohale. This funding marks a crucial step in the nation’s efforts to combat the HIV epidemic.
Explain It To Me Like I’m 5: